The post-crisis regulatory clampdown on derivatives, intended to make the market safer, was widely derided as imposing an unworkable burden on ordinary companies trying to use the markets for hedging. But as Nick Jacob reports, Emir’s bark has been worse than its bite. There are still dangers ahead, but European companies’ risk management activity is hardly stumbling under the weight of regulation.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.